These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 9147435)
1. Unusual occurrence of spontaneous haematomas in three asymptomatic HIV-infected haemophilia patients a few days after the onset of ritonavir treatment. Ginsburg C; Salmon-Ceron D; Vassilief D; Rabian C; Rotschild C; Fontenay-Roupie M; Stieltjes N; Sicard D AIDS; 1997 Mar; 11(3):388-9. PubMed ID: 9147435 [No Abstract] [Full Text] [Related]
2. Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen. Clevenbergh P; Corcostegui M; Gérard D; Hieronimus S; Mondain V; Chichmanian RM; Sadoul JL; Dellamonica P J Infect; 2002 Apr; 44(3):194-5. PubMed ID: 12099750 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection. Calza L; Manfredi R; Pocaterra D; Chiodo F Int J STD AIDS; 2008 Aug; 19(8):541-4. PubMed ID: 18663041 [TBL] [Abstract][Full Text] [Related]
5. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir. Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639 [TBL] [Abstract][Full Text] [Related]
6. Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Chaubey SK; Sinha AK; Phillips E; Russell DB; Falhammar H Sex Health; 2009 Sep; 6(3):254-7. PubMed ID: 19653965 [TBL] [Abstract][Full Text] [Related]
7. Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with antiretroviral resistance. Molina JM; Ait-Khaled M; Rinaldi R; Penco G; Baril JG; Cauda R; Soriano V; Pialoux G; Wire MB; Lou Y; Givens N; Craig C; Nichols WG; Barbosa I; Yeo J; J Antimicrob Chemother; 2009 Aug; 64(2):398-410. PubMed ID: 19515730 [TBL] [Abstract][Full Text] [Related]
8. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus. Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112 [TBL] [Abstract][Full Text] [Related]
9. Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial. Dragsted UB; Gerstoft J; Pedersen C; Peters B; Duran A; Obel N; Castagna A; Cahn P; Clumeck N; Bruun JN; Benetucci J; Hill A; Cassetti I; Vernazza P; Youle M; Fox Z; Lundgren JD; J Infect Dis; 2003 Sep; 188(5):635-42. PubMed ID: 12934178 [TBL] [Abstract][Full Text] [Related]
10. Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients. Nadler JP; Gathe JC; Pollard RB; Richmond GJ; Liao Q; Griffith S; Lancaster CT; Hernandez JE; Pappa KA; BMC Infect Dis; 2003 Jun; 3():10. PubMed ID: 12795812 [TBL] [Abstract][Full Text] [Related]
11. Interaction between ritonavir and levothyroxine. Tseng A; Fletcher D AIDS; 1998 Nov; 12(16):2235-6. PubMed ID: 9833871 [No Abstract] [Full Text] [Related]
12. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis. Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771 [TBL] [Abstract][Full Text] [Related]
13. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990 [TBL] [Abstract][Full Text] [Related]
14. [New treatment options for HIV-infected patients]. Wehr A Dtsch Med Wochenschr; 2004 May; 129(19):1093. PubMed ID: 15174468 [No Abstract] [Full Text] [Related]
15. Severe bruising in an HIV-positive patient with haemophilia after using a needle-free gas-powered injection device. Yoong D; Loufty M; Chin T; Bayoumi AM AIDS; 2007 Jul; 21(11):1499-500. PubMed ID: 17589206 [No Abstract] [Full Text] [Related]
16. Risk factors for ritonavir intolerance and outcome after change to indinavir. Casado JL; Perez-Elías MJ; Antela A; Martí-Belda P; de Lucas S; Muñoz V; Guerrero A AIDS; 1998 Feb; 12(3):335-6. PubMed ID: 9580044 [No Abstract] [Full Text] [Related]
17. Revision of ritonavir starting dose. AIDS Patient Care STDS; 1996 Aug; 10(4):261. PubMed ID: 11361602 [No Abstract] [Full Text] [Related]
18. Ritonavir, triglycerides, and pancreatitis. Perry RC; Cushing HE; Deeg MA; Prince MJ Clin Infect Dis; 1999 Jan; 28(1):161-2. PubMed ID: 10028103 [No Abstract] [Full Text] [Related]
19. Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infection. Kaplan SS; Hicks CB J Antimicrob Chemother; 2005 Aug; 56(2):273-6. PubMed ID: 15994247 [TBL] [Abstract][Full Text] [Related]
20. Using ritonavir with indinavir in cases of virologic failure. TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095 [No Abstract] [Full Text] [Related] [Next] [New Search]